בוטרנס 10 Izrael - hebrejština - Ministry of Health

בוטרנס 10

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 10 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

בוטרנס 20 Izrael - hebrejština - Ministry of Health

בוטרנס 20

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

רייאטאז 300 מג Izrael - hebrejština - Ministry of Health

רייאטאז 300 מג

bristol - myers squibb, israel - atazanavir as sulfate - קפסולות - atazanavir as sulfate 300 mg - atazanavir

סלספט 250 מג Izrael - hebrejština - Ministry of Health

סלספט 250 מג

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - קפסולות - mycophenolate mofetil 250 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

סלספט 500 מג Izrael - hebrejština - Ministry of Health

סלספט 500 מג

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - טבליות מצופות פילם - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

מיקופנולט טבע  500 מג Izrael - hebrejština - Ministry of Health

מיקופנולט טבע 500 מג

teva israel ltd - mycophenolate mofetil - טבליה - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, in patients receiving allogenic cardiac transplants and in allogenic hepatic transplants. mycophenolate teva should be used concomitantly with ciclosporin and corticosteroids.

מפטיל 500 Izrael - hebrejština - Ministry of Health

מפטיל 500

rafa laboratories ltd - mycophenolate mofetil 500 mg - film coated tablets - mycophenolic acid - prophylaxis of rejection in renal allograft recipients, and in patients receiving allogenic cardiac transplants. allogenic hepatic transplant. mefetil should be used concomitantly with cyclosporin and corticosteroids.

מפטיל 250 Izrael - hebrejština - Ministry of Health

מפטיל 250

rafa laboratories ltd - mycophenolate mofetil 250 mg - capsules - mycophenolic acid - prophylaxis of rejection in renal allograft recipients, and in patients receiving allogenic cardiac transplants. allogenic hepatic transplant. mefetil should be used concomitantly with cyclosporin and corticosteroids.

אפרקס 1000 Izrael - hebrejština - Ministry of Health

אפרקס 1000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

אפרקס 2000 Izrael - hebrejština - Ministry of Health

אפרקס 2000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 2000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat